United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Healthcare Industry News Technology Industry News Why Veeva Systems (NYSE: VEEV) stock dropped after earnings despite strong Q3 FY2026 results Find out how Veeva Systems beat Q3 expectations but still saw its stock drop — and what it means for growth, AI strategy, and investor sentiment. byPallavi MadhirajuNovember 21, 2025